Nanhua Bio-Medicine Co.,Ltd. Posted 8.2 Million Yuan Net Profit in First Three Quarters of 2022

Nanhua Bio-Medicine Co.,Ltd. (南华生物医药股份有限公司) (000504.SZ) reported a net profit of 8.2 million yuan in the first three quarters of 2022, reversing a net loss of 5.4 million yuan for the same period in the previous year.

Meanwhile, the company posted 156.4 million yuan in revenue, up 52.4% year-on-year.

At the end of the reporting period, it had 596 million yuan in total assets and 477.5 million yuan in total liabilities, with a liability-to-asset ratio of 80.1%.